Background and aim:No previous study investigated the anatomical changes of the scalp and hair follicles between tertiary androgenetic alopecia and severe alopecia areata using high-resolution magnetic resonance imaging (HR-MRI). This study aimed to explore the value of HR-MRI in assessing alopecia.Materials and methods: Forty-eight people were included in this study. The imaging indicators of the vertex and occipital scalp were recorded and compared. The logistic regression model was developed for the indicators that differed between tertiary androgenetic alopecia and severe alopecia areata. The receiver-operating characteristic (ROC) curve was used to assess the diagnostic efficacy of the model for tertiary androgenetic alopecia and severe alopecia areata.Results: At the vertex, the thickness of the subcutaneous tissue layer, follicle depth, relative follicle depth, total number of follicles within a 2-cm distance, and number of strands reaching the middle and upper third of the subcutaneous fat layer within a 2-cm distance were statistically different between patients with tertiary androgenetic alopecia, those with severe alopecia areata, and healthy volunteers (p < 0.05). The logistic regression model suggested that the subcutaneous tissue layer thickness was important in discriminating tertiary androgenetic alopecia from severe alopecia areata.The ROC curve showed that the area under the curve, sensitivity, specificity, and best cutoff values of the subcutaneous tissue layer were 0.886, 94.4%, 70%, and 4.31 mm, respectively.Conclusions: HR-MRI can observe the changes in anatomical structures of the scalp and hair follicles in patients with alopecia. HR-MRI can be applied to the differential diagnosis of tertiary androgenetic alopecia and severe alopecia areata.
Background Dermatofibrosarcoma protuberans (DFSP) is a kind of low‐grade malignant spindle cell neoplasm, the diagnosis, and treatment, which have markedly attracted clinicians’ attention for its repeated recurrence. High‐resolution magnetic resonance imaging (HR‐MRI) has shown unique capabilities in diagnosis of various cutaneous tumors. Materials and methods Data of 29 patients with clinically suspected DFSPs and undergoing dynamic contrast‐enhanced (DCE) HR‐MRI preoperatively were prospectively collected. The HR‐MRI qualitative features were evaluated and compared. The DCE‐associated quantitative parameters and the time‐signal intensity curve (TIC) types were provided using DCE sequences. Results A total of 7 DFSPs, nine dermatofibromas (DF, including four cases of cellular variant [CDF]), 12 keloids, and one nodular fasciitis were enrolled. DFSP showed the largest major diameter and the deepest depth. Five DFSPs (71.4%) showed ill‐defined margins as well as infiltration of peripheral adipose. All DFSPs showed irregular shape. Most DFSPs presented hyperintensity on T2WI (71.4%) and iso‐intensity on T1WI (85.7%). Six cases (85.7%) had significant enhancement, and six cases (85.7%) had homogeneous enhancement. There were significant differences of Ktrans, Kep, Ve and iAUC values among DFSPs, DFs, and keloids, and DFSP had the highest values for these parameters. Six DFSPs (85.7%) and four CDFs (100%) showed type‐III TICs, while the other lesions showed type‐Ⅰor type‐Ⅱ TICs. Conclusions DCE‐HR‐MRI could show the growth characteristics of DFSPs, which was of great value for the diagnosis and differential diagnosis of DFSPs and was helpful for the determination of treatment options, thereby to improve the prognosis of patients.
Background: How to reduce the radiation dose received from full-body CT scans during the follow-up of lymphoma patients is a concern. Objective: To investigate the image quality and radiation dose of reduced-dose full-body computerized tomography [CT] in lymphoma patients during follow-up. Methods: 121 patients were included and divided into conventional CT group [group 1, 120-kVp, n = 61] or reduced-dose CT group [group 2, 100-kVp combined dual-energy CT [DECT], n = 60]. 140-kVp polychromatic images and 70-keV monochromatic images were reconstructed from DECT. The abdominal virtual non-enhanced [VNE] images were reconstructed from monochromatic images. Two radiologists rated the overall image quality with a five-point scale and graded the depiction of lesions using a four-point scale. The objective image quality was evaluated using image noise, signal-to-noise ratio, contrast-to-noise ratio. The radiation dose and image quality were compared between groups. Results: The comparable subjective image quality was observed between 70-keV and 120-kVp images in the neck, while 120-kVp images showed better objective image quality. 70-keV images showed better objective image quality in the chest. While the subjective image quality of abdominal VNE images was inferior to that of true non-enhanced images, the improved objective image quality was observed in VNE images. In the abdominal arterial phase, similar subjective image quality was observed between groups. Abdominal 70-keV images in the arterial phase showed improved objective image quality. Similar image quality was obtained in the abdominal venous phase between groups. The effevtive radiation dose in group 2 showed a significant reduction. Conclusion: The application of reduced-dose full-body CT can significantly reduce the radiation dose for lymphoma patients during follow-up while maintaining or improving image quality.
Dermatofibrosarcoma protuberans (DFSP) is a type of intermediately malignant cutaneous spindle cell neoplasms, which is easy to be confused with several benign ones even after needle biopsy, especially cellular fibrous histiocytoma (cFH), resulting in inadequate excision and local recurrence. We found that as a novel skin imaging technique, high-resolution (HR) DCE MRI could distinguish DFSP. The features include infiltration of surrounding fat, ill-defined margins and large quantitative parameters. Both DFSP and cFH have type-III time-signal intensity curves (TICs). In contrast, other confused lesions presented type-II-or-I TIC. The recommendation of preoperative HR-MRI could assist dermatologists to perform surgical plan more confidently.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.